Patients with a nonrejection-related diagnosis according to the 2019 Banff classification who were reclassified as MVI, ...
The following is a summary of “Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback